Announced
Completed
A consortium of investor led a $95m investment round in OneSource Specialty Pharma.
Synopsis
A consortium of investor led a $95m investment round in OneSource Specialty Pharma, a specialty pharma pure-play CDMO business, with participation from White Oak Capital.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Bidder Team (3)
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite